Multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides) ( DrugBank: Myelin )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
13多発性硬化症/視神経脊髄炎1

13. 多発性硬化症/視神経脊髄炎


臨床試験数 : 3,340 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01448252
(ClinicalTrials.gov)
May 20025/10/2011T Cell Vaccination in Patients With Progressive Multiple SclerosisAutologous T Cell Vaccination With Line Specific for 9 Myelin Peptides in Patients With Progressive / Relapsing Multiple SclerosisMultiple SclerosisBiological: multiple (4 autologous subcutaneous T cell vaccinations with T cell lines reactive to nine myelin peptides);Biological: T cell vaccinationHadassah Medical OrganizationNULLCompleted18 Years60 YearsBoth30Phase 1/Phase 2Israel